The effects of the muscarinic antagonist scopolamine (0.1–0.6 mg/kg, IP) and the nicotinic
antagonist mecamylamine (1–10 mg/kg) were compared in T-maze alternation and …

The effects on working memory of the muscarinic cholinergic agonists oxotremorine,
arecoline, RS86 and pilocarpine, and the cholinesterase inhibitors physostigmine and …

Controversy exists whether the cholinergic system in the brain is involved in working
memory (WM) selectively or in both WM and reference memory (RM). Rats were trained to …

Rationale Scopolamine, a muscarinic antagonist, impairs learning and memory for many
tasks, supporting an important role for the cholinergic system in these cognitive functions …

Rats were trained to run in a spatial, radial arm maze using a procedure to determine two
memory functions, working and reference memory. The muscarinic antagonist, not the …

In recent years muscarinic receptor agonists and cholinesterase inhibitors have been
developed for the treatment of Alzheimer's disease. We have evaluated examples from both …

In order to clarify the interactions between monoaminergic and cholinergic systems in
working and reference memory functions, the effects of administration of the α, β-adrenergic …

The focus of this study was to analyze whether the psychostimulant nicotine would enhance
reference and working memory consolidation in rats tested on the 8-arm radial arm maze …

The promnesic effects of RU 35 926 (CI-979), a muscarinic receptor agonist, were evaluated
on memory impairments induced by the muscarinic antagonist scopolamine, using a radial …

Cholinergic receptor antagonists are commonly used to model attentional and mnemonic
impairments associated with neuropsychiatric disorders such as Alzheimer's disease …